Form 4: Ideaya Biosciences Director Exercises Stock Options
SEC Form 4 Filing
Susan L. Kelley, a director at Ideaya Biosciences, exercised stock options to acquire 16,200 shares of common stock on May 31, 2024.
Summary
- On May 31, 2024, Susan L. Kelley, a director of Ideaya Biosciences, Inc., executed a transaction involving derivative securities.
- Kelley exercised stock options, acquiring 16,200 shares of common stock at a price of $36.55 per share.
- Following the transaction, Kelley directly owns 16,200 shares of Ideaya Biosciences common stock through stock options.
- A Power of Attorney was executed on May 22, 2024, granting certain officers of Ideaya Biosciences the authority to act on Kelley's behalf for SEC filings.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions and is a standard practice for publicly traded companies. It provides transparency into the actions of company directors.
Stakeholder Impact
- The transaction may have a minor dilutive effect on existing shareholders due to the issuance of new shares.
Key Dates
| Date | Description |
|---|---|
| 2024-05-22 | Power of Attorney executed, granting authority to certain Ideaya Biosciences officers for SEC filings on behalf of Susan L. Kelley. |
| 2024-05-31 | Date of transaction: Susan L. Kelley exercised stock options. |
| 2034-05-30 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.